肿瘤坏死因子受体1和2与脑出血风险相关
该研究基于MDCS队列的巢式病例对照设计,纳入220例随访期间发生脑出血的患者和244例匹配对照,发现血浆TNFR1和TNFR2水平较高与脑出血风险增加相关,尤其非脑叶出血,且与致命性出血和不良功能结局相关。
要点
- 血浆TNFR1和TNFR2升高与脑出血风险独立相关。
- 非脑叶出血的关联强度高于脑叶出血。
- TNFR1和TNFR2亦与致命性出血及不良功能结局相关。
核心结论
- 高血浆TNFR1和TNFR2水平与脑出血风险增加相关,以非脑叶出血最为明显。
研究设计与样本
- 基于MDCS人群队列(n=28 449)的巢式病例对照研究,纳入220例脑出血患者和244例匹配对照。
主要发现
- 调整脑出血危险因素后,TNFR1的OR为2.28(95%CI 1.26-4.11,P=0.006),TNFR2的OR为1.77(95%CI 1.16-2.70,P=0.008)。
- 非脑叶出血的OR分别为TNFR1 3.04(95%CI 1.29-7.14)和TNFR2 2.39(95%CI 1.32-4.32)。
- 致命性出血的OR分别为TNFR1 4.42(95%CI 1.67-11.6)和TNFR2 2.90(95%CI 1.50-5.58)。
- TNFR1和TNFR2亦与改良Rankin量表评估的不良功能结局相关。
临床怎么用
- TNFR1和TNFR2或可作为脑出血风险分层的潜在生物标志物,但需进一步验证。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND AND PURPOSE: Raised plasma concentrations of tumor necrosis factor receptors (TNFR) have been linked to arterial stiffness, cerebral microbleeds, and vascular events. The aim of this study was to investigate the association of circulating levels of TNFR1 and TNFR2 with risk for future intracerebral hemorrhage (ICH). METHODS: The population-based MDCS cohort (Malmö Diet and Cancer Study; n=28 449) was conducted in 1991 to 1996. A nested case-control study was performed in the MDCS, including 220 cases who experienced ICH during the follow-up period (mean age at inclusion 62 years, 48% men) and 244 matched controls. Of the 220 ICH cases, 68 died within 28 days. Conditional logistic regression was used to study the association between plasma levels of TNFR1 and TNFR2 and incident ICH, adjusting for known ICH risk factors. RESULTS: Concentrations of both TNFR1 and TNFR2 were significantly higher in subjects who developed ICH during the follow-up. The associations remained after adjustment for ICH risk factors (TNFR1: odds ratio [OR], 2.28; 95% confidence interval [CI], 1.26-4.11; P=0.006; TNFR2: OR, 1.77; CI, 1.16-2.70; P=0.008). ORs were somewhat higher for nonlobar ICH (3.04; CI, 1.29-7.14 and 2.39; CI, 1.32-4.32, respectively) than for lobar ICH (2.03; CI, 0.93-4.41 and 1.35; CI, 0.78-2.37, respectively). TNFR1 and TNFR2 were also associated with increased risk of fatal ICH (TNFR1: OR, 4.42; CI, 1.67-11.6; TNFR2: OR, 2.90; CI, 1.50-5.58) and with poor functional outcome according to the modified Rankin Scale. CONCLUSIONS: High plasma levels of TNFR1 and TNFR2 were associated with incident ICH, most clearly with ICH of nonlobar location. The results suggest that tumor necrosis factor-mediated inflammation could be associated with vascular changes preceding ICH.
引用
- Svensson EH, Söderholm M, Abul-Kasim K, et al. Tumor Necrosis Factor Receptor 1 and 2 Are Associated With Risk of Intracerebral Hemorrhage. Stroke. 2017. PMID: 28830973. doi:10.1161/STROKEAHA.117.017849
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。